20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lifestance Health Group Inc (LFST) operates in the MEDICAL CARE FACILITIES industry and is headquartered in Scottsdale, United States with about 8,542 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, LFST reported $1.4B in revenue and $10M in net income.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
Interactive charts & full statements → Open the LFST valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.6B | $1.4B | $1.3B | $1.1B | $860M | $668M | $377M | $213M |
| Gross Profit | $532M | $461M | $402M | $302M | $237M | $202M | $134M | $62M |
| Gross Margin % | 33.6% | 32.4% | 32.2% | 28.6% | 27.6% | 30.2% | 35.6% | 29.4% |
| Operating Income (EBIT) | $78M | $24M | ($32M) | ($189M) | ($210M) | ($286M) | $15M | $15M |
| Operating Margin % | 5.0% | 1.7% | -2.5% | -17.9% | -24.4% | -42.9% | 4.1% | 7.2% |
| Net Income | $51M | $10M | ($57M) | ($186M) | ($216M) | ($307M) | ($38M) | $6M |
| Net Margin % | 3.2% | 0.7% | -4.6% | -17.6% | -25.1% | -46.0% | -10.1% | 2.7% |
| EBITDA | $132M | $79M | $40M | ($105M) | ($144M) | ($240M) | $9M | $19M |
| Earnings Per Share (EPS) | $0.13 | $0.02 | $-0.15 | $-0.51 | $-0.61 | $-0.94 | $-0.10 | $0.02 |
| Shares Outstanding (M) | 387M | 391M | 379M | 367M | 355M | 328M | 374M | 374M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $435M | $403M | $382M | $364M | $345M | $333M | $325M | $313M |
| Gross Profit | $153M | $136M | $126M | $117M | $108M | $110M | $109M | $100M |
| Gross Margin % | 35.1% | 33.7% | 33.0% | 32.0% | 31.4% | 33.0% | 33.6% | 32.1% |
| Operating Income (EBIT) | $31M | $22M | $18M | $7M | ($3M) | $2M | $1M | $0M |
| Operating Margin % | 7.0% | 5.5% | 4.7% | 2.0% | -0.9% | 0.5% | 0.3% | 0.0% |
| Net Income | $24M | $14M | $12M | $1M | ($4M) | $1M | ($7M) | ($6M) |
| Net Margin % | 5.4% | 3.5% | 3.0% | 0.3% | -1.1% | 0.2% | -2.2% | -1.9% |
| EBITDA | $44M | $35M | $32M | $21M | $11M | $15M | $15M | $15M |
| Earnings Per Share (EPS) | $0.06 | $0.04 | $0.03 | $0.00 | $-0.01 | $0.00 | $-0.02 | $-0.02 |
| Shares Outstanding (M) | 387M | 395M | 393M | 389M | 387M | 391M | 380M | 380M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $218M | $146M | $107M | ($17M) | $53M | $9M | ($9M) | $17M |
| Capital Expenditures (CapEx) | $58M | $36M | $22M | $41M | $79M | $94M | $38M | $14M |
| Free Cash Flow (FCF) | $160M | $110M | $86M | ($57M) | ($26M) | ($85M) | ($47M) | $3M |
| FCF Margin % | 10.1% | 7.7% | 6.9% | -5.4% | -3.1% | -12.7% | -12.3% | 1.3% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $100M | $33M | $58M | $27M | $64M | ($3M) | $62M | $23M |
| Capital Expenditures (CapEx) | $12M | $11M | $25M | $10M | $8M | $7M | $6M | $5M |
| Free Cash Flow (FCF) | $88M | $22M | $32M | $17M | $57M | ($10M) | $56M | $18M |
| FCF Margin % | 20.2% | 5.5% | 8.5% | 4.7% | 16.4% | -3.1% | 17.2% | 5.7% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.2B | $2.2B | $2.1B | $2.1B | $2.2B | $1.9B | $1.6B | $281M |
| Cash & Cash Equivalents | $226M | $249M | $155M | $79M | $109M | $148M | $19M | $3M |
| Total Liabilities | $704M | $683M | $672M | $681M | $655M | $382M | $572M | $447M |
| Total Debt (Short + Long-Term) | $305M | $311M | $336M | $330M | $266M | $159M | $366M | $80M |
| Total Shareholders' Equity | $1.5B | $1.5B | $1.4B | $1.4B | $1.5B | $1.5B | $998M | ($166M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LFST viewer.
About TickerBase · Data methodology & sources · Privacy · Terms